Letter: Clorazepate dipotassium in tardive dyskinesia.
D000368:Aged; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy; D002264:Carboxylic Acids / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000009:adverse effects; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy
D014151:Anti-Anxiety Agents; D002264:Carboxylic Acids; D011619:Psychotropic Drugs; D001569:Benzodiazepines